Lifang Li
- Pharmacology top 10%
- Apelin-related biomedical research 3
- Rehabilitation top 10%
- Stroke Rehabilitation and Recovery 2
-
- CRISPR and Genetic Engineering 4
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 3
-
- Balance, Gait, and Falls Prevention 3
-
- Nuclear Receptors and Signaling 3
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 2
-
- Plant Virus Research Studies 2
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Lifang Li
26 papers receiving 702 citations
Peers
Comparison fields: 5 of 95
- Computer Networks and Communications 292
- Pharmacology 117
- Electrical and Electronic Engineering 355
- Rehabilitation 36
- Business and International Management 10
Countries citing papers authored by Lifang Li
This map shows the geographic impact of Lifang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifang Li more than expected).
Fields of papers citing papers by Lifang Li
This network shows the impact of papers produced by Lifang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifang Li. The network helps show where Lifang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lifang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 29 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 18 | |
| 12 | 2021 | 26 | |
| 13 | 2021 | 5 | |
| 14 | 2019 | 13 | |
| 15 | 2018 | 9 | |
| 16 | 2015 | 21 | |
| 17 | 2015 | 55 | |
| 18 | 2015 | 10 | |
| 19 | 2013 | 67 | |
| 20 | 2001 | 363 |
About Lifang Li
Lifang Li is a scholar working on Physical Therapy, Sports Therapy and Rehabilitation, Instrumentation and Rehabilitation, having authored 30 papers that have together received 735 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (4 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers), Balance, Gait, and Falls Prevention (3 papers), Apelin-related biomedical research (3 papers), Nuclear Receptors and Signaling (3 papers), Stroke Rehabilitation and Recovery (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Plant Virus Research Studies (2 papers). The work is most often cited by research in Computer Networks and Communications (292 citations), Pharmacology (117 citations) and Electrical and Electronic Engineering (355 citations). Lifang Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Andrea Goldsmith, Lanfang Li, Linxi Chen, Deguan Lv, Le Li, Zidong Zhang, Zheng Hu, Yu Guo, Guotao Tang and Rui Tian.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.